Open access · US-GOV via ClinicalTrials.gov Clinical trial

Long-term Effects of Expanded Hemodialysis in Reduction of Large Middle Molecules in Chronic Hemodialysis Patients: Potential Benefits to the Prevention of Sarcopenia

Authors not listed

Gangnam Severance Hospital · 2020

Stem-cell exhaustion Human Randomized controlled trial

Abstract

The current study will investigate whether long term implementation of expanded hemodialysis (HDx) will effectively decrease serum levels of large uremic toxins and ameliorate progression of sarcopenia in patients with chronic kidney disease requiring hemodialysis.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-07-02 MST

Cite this

APA

Anonymous. (2020). Long-term Effects of Expanded Hemodialysis in Reduction of Large Middle Molecules in Chronic Hemodialysis Patients: Potential Benefits to the Prevention of Sarcopenia. <em>Gangnam Severance Hospital</em>. https://clinicaltrials.gov/study/NCT04585607

Vancouver

Anonymous. Long-term Effects of Expanded Hemodialysis in Reduction of Large Middle Molecules in Chronic Hemodialysis Patients: Potential Benefits to the Prevention of Sarcopenia. Gangnam Severance Hospital. 2020.

BibTeX

@misc{anon2020Longte, title = {Long-term Effects of Expanded Hemodialysis in Reduction of Large Middle Molecules in Chronic Hemodialysis Patients: Potential Benefits to the Prevention of Sarcopenia}, author = {Anonymous}, journal = {Gangnam Severance Hospital}, year = {2020}, }